Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Sho

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Interferon therapy for chronic hepatitis B]Shuhei Hige, Takuya Sho, Mitsuru Nakanishi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2026
Corticosteroid rescue of immune checkpoint inhibitor-induced hepatitis triggers HCV reactivation in HCV-related HCCGoki Suda, Masatsugu Ohara, Masato Nakai, et al.
Biochemical and Biophysical Research Communications|November 27, 2010
RNF43 interacts with NEDL1 and regulates p53-mediated transcriptionKeisuke Shinada, Tadasuke Tsukiyama, Takuya Sho, et al.
Journal of Clinical and Translational Hepatology|January 19, 2017
Novel Treatment of Hepatitis C Virus Infection for Patients with Renal ImpairmentGoki Suda, Koji Ogawa, Megumi Kimura, et al.
Biochimica Et Biophysica Acta|April 6, 2011
TRIM29 negatively regulates p53 via inhibition of Tip60Takuya Sho, Tadasuke Tsukiyama, Tomonobu Sato, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 29, 2026
Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C PatientsNobuharu Tamaki, Masayuki Kurosaki, Hironori Ochi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 13, 2025
Soluble Cluster of Differentiation 14 as a Prognostic Marker in Decompensated Cirrhosis With Water RetentionMasato Nakai, Masatsugu Ohara, Daisuke Yokoyama, et al.
Journal of Gastroenterology|March 31, 2012
Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis CTomoe Kobayashi, Shuhei Hige, Katsumi Terashita, et al.
Journal of Clinical Microbiology|October 8, 2010
Sensitive assay for quantification of hepatitis B virus mutants by use of a minor groove binder probe and peptide nucleic acidsShuhei Hige, Yoichi Yamamoto, Shigeru Yoshida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2017
Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosisMasato Nakai, Koji Ogawa, Rei Takeda, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 22, 2011
[Interferon therapy for chronic hepatitis B]Shuhei Hige, Takuya Sho, Mitsuru Nakanishi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2026
Corticosteroid rescue of immune checkpoint inhibitor-induced hepatitis triggers HCV reactivation in HCV-related HCCGoki Suda, Masatsugu Ohara, Masato Nakai, et al.
Biochemical and Biophysical Research Communications|November 27, 2010
RNF43 interacts with NEDL1 and regulates p53-mediated transcriptionKeisuke Shinada, Tadasuke Tsukiyama, Takuya Sho, et al.
Journal of Clinical and Translational Hepatology|January 19, 2017
Novel Treatment of Hepatitis C Virus Infection for Patients with Renal ImpairmentGoki Suda, Koji Ogawa, Megumi Kimura, et al.
Biochimica Et Biophysica Acta|April 6, 2011
TRIM29 negatively regulates p53 via inhibition of Tip60Takuya Sho, Tadasuke Tsukiyama, Tomonobu Sato, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 29, 2026
Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C PatientsNobuharu Tamaki, Masayuki Kurosaki, Hironori Ochi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 13, 2025
Soluble Cluster of Differentiation 14 as a Prognostic Marker in Decompensated Cirrhosis With Water RetentionMasato Nakai, Masatsugu Ohara, Daisuke Yokoyama, et al.
Journal of Gastroenterology|March 31, 2012
Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis CTomoe Kobayashi, Shuhei Hige, Katsumi Terashita, et al.
Journal of Clinical Microbiology|October 8, 2010
Sensitive assay for quantification of hepatitis B virus mutants by use of a minor groove binder probe and peptide nucleic acidsShuhei Hige, Yoichi Yamamoto, Shigeru Yoshida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2017
Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosisMasato Nakai, Koji Ogawa, Rei Takeda, et al.
Pageof 12